HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jeffrey S Berger Selected Research
Jeffrey S Berger Research Topics
Disease
48
Hemorrhage
10/2022 - 01/2006
41
Myocardial Infarction
01/2022 - 06/2005
35
Peripheral Arterial Disease
05/2022 - 05/2009
25
Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 01/2006
24
Stroke (Strokes)
01/2022 - 01/2006
19
Ischemic Stroke
01/2022 - 01/2006
16
Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 06/2005
14
Inflammation (Inflammations)
01/2022 - 05/2011
14
COVID-19
01/2022 - 01/2020
14
Ischemia
01/2022 - 08/2013
13
Coronary Disease (Coronary Heart Disease)
10/2021 - 09/2004
12
Thrombosis (Thrombus)
01/2022 - 05/2006
12
Atherosclerosis
01/2021 - 06/2005
11
Diabetes Mellitus
01/2022 - 01/2012
11
Atrial Fibrillation
11/2021 - 08/2016
9
Obesity
10/2022 - 01/2018
8
Venous Thromboembolism
11/2022 - 05/2015
7
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 01/2019
7
Acute Coronary Syndrome
12/2018 - 11/2008
6
Critical Illness (Critically Ill)
01/2022 - 01/2020
5
Hypertension (High Blood Pressure)
01/2022 - 04/2006
5
Unstable Angina
01/2022 - 02/2005
4
Body Weight (Weight, Body)
11/2022 - 01/2019
4
Morbid Obesity
10/2022 - 01/2019
4
Neoplasms (Cancer)
10/2022 - 12/2009
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 05/2012
4
Hyperglycemia
10/2019 - 05/2014
4
Heart Failure
02/2019 - 09/2016
3
Thrombocytopenia (Thrombopenia)
01/2022 - 01/2019
3
Infections
01/2022 - 03/2009
3
Chronic Renal Insufficiency
12/2021 - 01/2017
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 01/2018
3
Atherosclerotic Plaque (Atheroma)
01/2021 - 01/2019
3
Insulin Resistance
10/2020 - 02/2013
3
Chronic Limb-Threatening Ischemia
01/2020 - 01/2012
3
Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2018 - 01/2008
3
Vascular Diseases (Vascular Disease)
01/2018 - 08/2009
3
Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 01/2008
3
ST Elevation Myocardial Infarction
01/2014 - 01/2008
2
Wounds and Injuries (Trauma)
03/2022 - 10/2021
2
Dementia (Dementias)
01/2022 - 01/2021
2
Transient Ischemic Attack
01/2022 - 01/2018
2
Pulmonary Embolism
01/2022 - 01/2018
2
Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 01/2018
2
Anemia
12/2021 - 03/2016
Drug/Important Bio-Agent (IBA)
28
Clopidogrel (Plavix)
FDA Link
05/2022 - 11/2008
24
Ticagrelor
IBA
01/2022 - 09/2013
22
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
11/2022 - 01/2006
11
Rivaroxaban
IBA
10/2022 - 01/2017
11
omega-Chloroacetophenone (Mace)
IBA
10/2021 - 07/2017
10
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2008
7
Warfarin (Coumadin)
FDA Link
Generic
10/2022 - 10/2017
7
Cholesterol
IBA
01/2021 - 04/2012
6
Lipids
IBA
01/2022 - 05/2011
6
HDL Lipoproteins
IBA
01/2021 - 02/2013
5
Heparin (Liquaemin)
FDA Link
Generic
01/2022 - 08/2016
5
RNA (Ribonucleic Acid)
IBA
09/2021 - 10/2016
5
Proteins (Proteins, Gene)
FDA Link
09/2021 - 06/2013
5
Interleukin-6 (Interleukin 6)
IBA
04/2021 - 06/2017
5
C-Reactive Protein
IBA
04/2021 - 04/2008
5
oxidized low density lipoprotein
IBA
01/2021 - 04/2012
4
Anticoagulants
IBA
10/2022 - 01/2018
4
P-Selectin
IBA
12/2021 - 08/2011
4
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
12/2021 - 12/2009
4
Cytokines
IBA
04/2021 - 06/2017
4
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2021 - 04/2012
4
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2020 - 01/2012
4
Glucose (Dextrose)
FDA Link
Generic
10/2018 - 05/2012
3
Adenosine Diphosphate (ADP)
IBA
01/2022 - 07/2013
3
Fibrinogen (Factor I)
FDA Link
01/2022 - 06/2013
3
Hemoglobins (Hemoglobin)
IBA
12/2021 - 03/2016
3
Pharmaceutical Preparations
IBA
01/2021 - 01/2018
3
Triglycerides (Triacylglycerol)
IBA
01/2021 - 04/2012
3
Lipoproteins (Lipoprotein)
IBA
10/2020 - 04/2012
3
Vitamin K
FDA Link
10/2018 - 01/2017
3
Troponin
IBA
08/2017 - 03/2013
2
Oxygen (Dioxygen)
IBA
01/2022 - 01/2022
2
fibrin fragment D (D-dimer)
IBA
01/2022 - 10/2020
2
Fibrinolytic Agents (Antithrombotic Agents)
IBA
12/2021 - 01/2021
2
Indicators and Reagents (Reagents)
IBA
04/2021 - 11/2006
2
Interleukins
IBA
04/2021 - 01/2021
2
Interleukin-17 (Interleukin 17)
IBA
04/2021 - 01/2021
2
Interferons
IBA
01/2021 - 01/2020
Therapy/Procedure
35
Therapeutics
01/2022 - 06/2005
15
Surgical Amputation (Amputations)
01/2022 - 01/2012
15
Percutaneous Coronary Intervention
01/2019 - 09/2004
8
Secondary Prevention
01/2022 - 01/2008
6
Perioperative Period
10/2019 - 03/2013
5
Stents
01/2020 - 04/2006
5
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2019 - 11/2008
4
Length of Stay
03/2022 - 11/2008
4
Critical Care (Surgical Intensive Care)
12/2021 - 01/2020
3
Patient Readmission
01/2022 - 01/2018
3
Artificial Respiration (Mechanical Ventilation)
05/2021 - 01/2020
3
Bariatric Surgery
10/2020 - 01/2019
3
Vascular Surgical Procedures
01/2020 - 01/2018
2
Knee Replacement Arthroplasty (Total Knee Replacement)
03/2022 - 03/2009
2
Conduction Anesthesia (Regional Anesthesia)
03/2022 - 10/2021
2
Polypharmacy
11/2021 - 01/2021
2
Conservative Treatment
01/2021 - 01/2018